l General Information |
Product Name | Betrixaban |
General description | Betrixaban is a highly potent, selective, and orally efficacious factor Xa (fXa) inhibitor |
Synonym | PRT054021; N-(5-chloropyridin-2-yl)-2-[[4-(N,N-dimethylcarbamimidoyl)benzoyl]amino]-5-methoxybenzamide |
Purity | ≥98.0%(HPLC) | CAS Number | 330942-05-7 |
Formula | C23H22ClN5O3 | Molecular Weight | 451.91 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | Solid |
Solubility(25°C) | DMSO | ≥25mg/ml |
Ethanol | Insoluble |
l Biological Information |
Biochem/Physiol
Actions | Betrixaban is an orally active inhibitor of coagulation factor Xa (activated factor X) with anticoagulant activity. Betrixaban is primarily excreted unchanged in the bile and has a half life of about 19 hours. |
l Storage |
Storage temp. | -20°C |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |
